Oncology Scan on CART! for diffuse large B cell lymphoma Rahul Parikh Rutgers Cancer Institute Sarah Milgrom, MD Belinda Campbell ILROG Team Get caught up at: redjournal.org/article/S0360-…

Congratulations to Bradford Hoppe on becoming an ACR Fellow this past weekend. Such an incredible accomplishment. Thank you for all you do for our residency! #radonc

#RadOnc needs THIS! IMGs are a (small but mighty) population that are overlooked when it comes to #DEI. As the landscape of trainees evolve, it’s time for a change! Knowledge + mentorship + sponsorship = DEI. #DEIinRO ACROresident ACRO - American College of Radiation Oncology ARRO ASTRO

Thank you Leah D'Souza, MD, MSc 🙏🙏. Can't agree more on this. #IMGs should strongly be considered in the context of #DEI. Omran Saifi, MD Mona Arbab, MD MEd Pranshu Mohindra Sushil May F. Elbanna Rituraj Upadhyay, MD Santanu Samanta BhanuPrasad Venkatesulu ARRO ASTRO

Study reports higher sustained complete response, lower local relapse, & improved relapse- & event-free survivals in non-Hodgkin lymphoma pts w/ <5 pre-CART disease sites who received comprehensive bridging radiation vs. no bridging radiation. Omran Saifi, MD ja.ma/3QEVDe1

Indeed, very excited to have #POSEIDON open Mayo Clinic Comprehensive Cancer Center! Special thanks to Bradford Hoppe for the excellent mentorship throughout the process, from developing the protocol to securing funding and managing logistics. If you’re wondering about the trial name, see the pic below, lol

Huge congrats to our residents Drs. Omran Saifi, MD, David Crompton & Bryan Johnson on having multiple abstracts accepted to ASTRO for the annual meeting! 3 orals for Omran Saifi, MD 🤩🤩🤩 Mayo Clinic Florida Radiation Oncology Residency Mayo Clinic Comprehensive Cancer Center ARRO #radonc.

Thanks to incredible Mayo Clinic Florida Radiation Oncology Residency Bradford Hoppe mentorship, PD Albert Attia support, Mayo Clinic Comprehensive Cancer Center Mayo Clinic Radiation Oncology collaboration, and endorsement from NRG Oncology Heme Group, among many others, I’m grateful to have those 7 #ASTRO orals. Excited for my last #ASTRO_24 as a resident!!

We highlight Journal of Clinical Oncology the importance of addressing RT tox that matters most to pts when comparing proton to IMRT for prostate ca. Protons can⬇️ low dose bath➡️reduce bowel freq/urg—two most bothersome tox for pts. Bradford Hoppe Albert Attia Mayo Clinic Comprehensive Cancer Center doi.org/10.1200/jco.24…

Active CNS 🧠 disease is a major challenge for #lymphoma pts planned for CAR T cells. CNS bridging #radiotherapy can rapidly cytoreduce these high risk pts. The Memorial Sloan Kettering Cancer Center initial experience out in Blood Advances Memorial Sloan Kettering Radiation Oncology ashpublications.org/bloodadvances/…

Study reports higher sustained complete response, lower local relapse, & improved relapse- & event-free survivals in non-Hodgkin lymphoma pts w/ <5 pre-CART disease sites who received comprehensive bridging radiation vs. no bridging radiation. ja.ma/4d3nvRG Omran Saifi, MD

Truly honored to receive Radiation Oncology Institute pub excellence award for work on RT+CAR-T! Grateful for mentors Bradford Hoppe Mohamed Kharfan-Dabaja, MD, MBA & our collaborative team Mayo Clinic Comprehensive Cancer Center tri-site: Scott Lester William Breen Bradley Stish Yi Lin Allison Rosenthal Muhamad Alhaj Moustafa, MD, MS Madiha Iqbal MD Hemant S. Murthy MD!